Pathogenesis of NEC: Role of the innate and adaptive immune response

Seminars in Perinatology

Volumn 41, Issue 1, 2017, Pages 15-28

  Denning, Timothy W ^a   Bhatia, Amina M ^b   Kane, Andrea F ^b   Patel, Ravi M ^b   Denning, Patricia W ^b  

^a GEORGIA STATE UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

adaptive intestinal immunity; innate intestinal immunity; Necrotizing enterocolitis; pathogenesis

Indexed keywords

GROWTH FACTOR; MILK PROTEIN; POLYPEPTIDE ANTIBIOTIC AGENT;

ADAPTIVE IMMUNITY; BACTERIAL COLONIZATION; BREAST MILK; CASE FATALITY RATE; CD4+ T LYMPHOCYTE; COMMENSAL; DENDRITIC CELL; DISEASE PREDISPOSITION; HOST RESISTANCE; HUMAN; IMMATURITY; IMMUNOREGULATION; INFANT; INNATE IMMUNITY; INTESTINE EPITHELIUM; LYMPHOCYTE; LYMPHOID CELL; MACROPHAGE; MORBIDITY; MUCUS; NATURAL KILLER CELL; NECROTIZING ENTEROCOLITIS; NEUTROPHIL; NONHUMAN; PASSIVE IMMUNIZATION; PATHOGENESIS; PATHOPHYSIOLOGY; PERMEABILITY BARRIER; PREMATURITY; REVIEW; STOMACH ACID; SURVIVOR; EVIDENCE BASED MEDICINE; IMMUNOLOGY; INTESTINE; INTESTINE MUCOSA; MICROBIOLOGY; VASCULARIZATION;

ADAPTIVE IMMUNITY; ENTEROCOLITIS, NECROTIZING; EVIDENCE-BASED MEDICINE; HUMANS; IMMUNITY, INNATE; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; INTESTINAL MUCOSA; INTESTINES; MILK, HUMAN;

EID: 85008210242     PISSN: 01460005     EISSN: 1558075X     Source Type: Journal    
DOI: 10.1053/j.semperi.2016.09.014     Document Type: Review

References (245)

1. 1 Heron, M., Deaths: leading causes for 2013. Natl Vital Stat Rep 65 (2016), 1–95.
2. 2 Lin, P.W., Stoll, B.J., Necrotising enterocolitis. Lancet 368 (2006), 1271–1283.
3. 3 Neu, J., Walker, W.A., Necrotizing enterocolitis. N Engl J Med 364 (2011), 255–264.
4. 4 Patel, R.M., Kandefer, S., Walsh, M.C., et al. Causes and timing of death in extremely premature infants from 2000 through 2011. N Engl J Med 372 (2015), 331–340.
5. 5 Stoll, B.J., Kanto, W.P. Jr, Glass, R.I., Nahmias, A.J., Brann, A.W. Jr, Epidemiology of necrotizing enterocolitis: a case control study. J Pediatr 96 (1980), 447–451.
6. 6 Guthrie, S.O., Gordon, P.V., Thomas, V., Thorp, J.A., Peabody, J., Clark, R.H., Necrotizing enterocolitis among neonates in the United States. J Perinatol 23 (2003), 278–285.
7. 7 Neu, J., Neonatal necrotizing enterocolitis: an update. Acta Paediatr Suppl 94 (2005), 100–105.
8. 8 Llanos, A.R., Moss, M.E., Pinzon, M.C., Dye, T., Sinkin, R.A., Kendig, J.W., Epidemiology of neonatal necrotising enterocolitis: a population-based study. Paediatr Perinat Epidemiol 16 (2002), 342–349.
9. 9 Cotten, C.M., Taylor, S., Stoll, B., et al. Prolonged duration of initial empirical antibiotic treatment is associated with increased rates of necrotizing enterocolitis and death for extremely low birth weight infants. Pediatrics 123 (2009), 58–66.
10. 10 Kenyon, S., Boulvain, M., Neilson, J.P., Antibiotics for preterm rupture of membranes. Cochrane Database Syst Rev, 2010, CD001058.
11. 11 Kuppala, V.S., Meinzen-Derr, J., Morrow, A.L., Schibler, K.R., Prolonged initial empirical antibiotic treatment is associated with adverse outcomes in premature infants. J Pediatr 159 (2011), 720–725.
12. 12 Alexander, V.N., Northrup, V., Bizzarro, M.J., Antibiotic exposure in the newborn intensive care unit and the risk of necrotizing enterocolitis. J Pediatr 159 (2011), 392–397.
13. 13 AlFaleh, K., Anabrees, J., Probiotics for prevention of necrotizing enterocolitis in preterm infants. Evid Based Child Health 9 (2014), 584–671.
14. 14 Warner, B.B., Deych, E., Zhou, Y., et al. Gut bacteria dysbiosis and necrotising enterocolitis in very low birthweight infants: a prospective case–control study. Lancet 387:10031 (2016), 1928–1936.
15. 15 de la Cochetiere, M.F., Piloquet, H., des Robert, C., Darmaun, D., Galmiche, J.P., Roze, J.C., Early intestinal bacterial colonization and necrotizing enterocolitis in premature infants: the putative role of Clostridium. Pediatr Res 56 (2004), 366–370.
16. 16 Wang, Y., Hoenig, J.D., Malin, K.J., et al. 16S rRNA gene-based analysis of fecal microbiota from preterm infants with and without necrotizing enterocolitis. ISME J 3 (2009), 944–954.
17. 17 Morrow, A.L., Lagomarcino, A.J., Schibler, K.R., et al. Early microbial and metabolomic signatures predict later onset of necrotizing enterocolitis in preterm infants. Microbiome, 1, 2013, 13.
18. 18 Mai, V., Young, C.M., Ukhanova, M., et al. Fecal microbiota in premature infants prior to necrotizing enterocolitis. PLoS One, 6, 2011, e20647.
19. 19 Greenwood, C., Morrow, A.L., Lagomarcino, A.J., et al. Early empiric antibiotic use in preterm infants is associated with lower bacterial diversity and higher relative abundance of Enterobacter. J Pediatr 165 (2014), 23–29.
20. 20 Torrazza, R.M., Ukhanova, M., Wang, X., et al. Intestinal microbial ecology and environmental factors affecting necrotizing enterocolitis. PLoS One, 8, 2013, e83304.
21. 21 Moles, L., Gomez, M., Heilig, H., et al. Bacterial diversity in meconium of preterm neonates and evolution of their fecal microbiota during the first month of life. PLoS One, 8, 2013, e66986.
22. 22 Claud, E.C., Keegan, K.P., Brulc, J.M., et al. Bacterial community structure and functional contributions to emergence of health or necrotizing enterocolitis in preterm infants. Microbiome, 1, 2013, 20.
23. 23 Madani, G., Heiner, D.C., Antibody transmission from mother to fetus. Curr Opin Immunol 1 (1989), 1157–1164.
24. 24 Cheng, M.M., Huang, C.F., Yang, L.Y., et al. Development of serum IgA and IgM levels in breast-fed and formula-fed infants during the first week of life. Early Hum Dev 88 (2012), 743–745.
25. 25 Niewiesk, S., Maternal antibodies: clinical significance, mechanism of interference with immune responses, and possible vaccination strategies. Front Immunol, 5, 2014, 446.
26. 26 Lawrence, R.M., Pane, C.A., Human breast milk: current concepts of immunology and infectious diseases. Curr Probl Pediatr Adolesc Health Care 37 (2007), 7–36.
27. 27 Palmeira, P., Quinello, C., Silveira-Lessa, A.L., Zago, C.A., Carneiro-Sampaio, M., IgG placental transfer in healthy and pathological pregnancies. Clin Dev Immunol, 2012, 2012, 985646.
28. 28 Gross, S.J., Buckley, R.H., Wakil, S.S., McAllister, D.C., David, R.J., Faix, R.G., Elevated IgA concentration in milk produced by mothers delivered of preterm infants. J Pediatr 99 (1981), 389–393.
29. 29 Schlesinger, L., Munoz, C., Arevalo, M., Arredondo, S., Mendez, G., Functional capacity of colostral leukocytes from women delivering prematurely. J Pediatr Gastroenterol Nutr 8 (1989), 89–94.
30. 30 Mehta, R., Petrova, A., Biologically active breast milk proteins in association with very preterm delivery and stage of lactation. J Perinatol 31 (2011), 58–62.
31. 31 Foster, J.P., Seth, R., Cole, M.J., Oral immunoglobulin for preventing necrotizing enterocolitis in preterm and low birth weight neonates. Cochrane Database Syst Rev, 4, 2016, CD001816.
32. 32 Shah, U., Dickinson, B.L., Blumberg, R.S., Simister, N.E., Lencer, W.I., Walker, W.A., Distribution of the IgG Fc receptor, FcRn, in the human fetal intestine. Pediatr Res 53 (2003), 295–301.
33. 33 Swanson, J.R., Jilling, T., Lu, J., Landseadel, J.B., Marcinkiewicz, M., Gordon, P.V., Ileal immunoglobulin binding by the neonatal Fc receptor: a previously unrecognized mechanism of protection in the neonatal rat model of necrotizing enterocolitis?. EJ Neonatol Res, 1, 2011.
34. 34 Pyzik, M., Rath, T., Lencer, W.I., Baker, K., Blumberg, R.S., FcRn: the architect behind the immune and nonimmune functions of IgG and albumin. J Immunol 194 (2015), 4595–4603.
35. 35 Jakaitis, B.M., Denning, P.W., Human breast milk and the gastrointestinal innate immune system. Clin Perinatol 41 (2014), 423–435.
36. 36 Chatterton, D.E., Nguyen, D.N., Bering, S.B., Sangild, P.T., Anti-inflammatory mechanisms of bioactive milk proteins in the intestine of newborns. Int J Biochem Cell Biol 45 (2013), 1730–1747.
37. 37 Goldman, A.S., The immune system of human milk: antimicrobial, antiinflammatory and immunomodulating properties. Pediatr Infect Dis J 12 (1993), 664–671.
38. 38 Newburg, D.S., Neonatal protection by an innate immune system of human milk consisting of oligosaccharides and glycans. J Anim Sci 87 (2009), 26–34.
39. 39 Underwood, M.A., Gaerlan, S., De Leoz, M.L., et al. Human milk oligosaccharides in premature infants: absorption, excretion, and influence on the intestinal microbiota. Pediatr Res 78 (2015), 670–677.
40. 40 Srinivasjois, R., Rao, S., Patole, S., Prebiotic supplementation in preterm neonates: updated systematic review and meta-analysis of randomised controlled trials. Clin Nutr 32 (2013), 958–965.
41. 41 Armanian, A.M., Sadeghnia, A., Hoseinzadeh, M., et al. The effect of neutral oligosaccharides on reducing the incidence of necrotizing enterocolitis in preterm infants: a randomized clinical trial. Int J Prev Med 5 (2014), 1387–1395.
42. 42 Nandhini, L.P., Biswal, N., Adhisivam, B., Mandal, J., Bhat, B.V., Mathai, B., Synbiotics for decreasing incidence of necrotizing enterocolitis among preterm neonates—a randomized controlled trial. J Matern Fetal Neonatal Med 29 (2016), 821–825.
43. 43 Jantscher-Krenn, E., Zherebtsov, M., Nissan, C., et al. The human milk oligosaccharide disialyllacto-N-tetraose prevents necrotising enterocolitis in neonatal rats. Gut 61 (2012), 1417–1425.
44. 44 Plaisancie, P., Claustre, J., Estienne, M., et al. A novel bioactive peptide from yoghurts modulates expression of the gel-forming MUC2 mucin as well as population of goblet cells and Paneth cells along the small intestine. J Nutr Biochem 24 (2013), 213–221.
45. 45 Lonnerdal, B., Bioactive proteins in human milk: mechanisms of action. J Pediatr 156 (2010), S26–S30.
46. 46 Thormar, H., Isaacs, C.E., Brown, H.R., Barshatzky, M.R., Pessolano, T., Inactivation of enveloped viruses and killing of cells by fatty acids and monoglycerides. Antimicrob Agents Chemother 31 (1987), 27–31.
47. 47 Newburg, D.S., Walker, W.A., Protection of the neonate by the innate immune system of developing gut and of human milk. Pediatr Res 61 (2007), 2–8.
48. 48 Ellison, R.T. 3rd, Giehl, T.J., Killing of gram-negative bacteria by lactoferrin and lysozyme. J Clin Invest 88 (1991), 1080–1091.
49. 49 Lonnerdal, B., Bioactive proteins in breast milk. J Paediatr Child Health 49:suppl 1 (2013), 1–7.
50. 50 Manzoni, P., Rinaldi, M., Cattani, S., et al. Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial. J Am Med Assoc 302 (2009), 1421–1428.
51. 51 Manzoni, P., Stolfi, I., Messner, H., et al. Bovine lactoferrin prevents invasive fungal infections in very low birth weight infants: a randomized controlled trial. Pediatrics 129 (2012), 116–123.
52. 52 Valenti, P., Antonini, G., Lactoferrin: an important host defence against microbial and viral attack. Cell Mol Life Sci 62 (2005), 2576–2587.
53. 53 Kuwata, H., Yip, T.T., Tomita, M., Hutchens, T.W., Direct evidence of the generation in human stomach of an antimicrobial peptide domain (lactoferricin) from ingested lactoferrin. Biochim Biophys Acta 1429 (1998), 129–141.
54. 54 Pammi, M., Abrams, S.A., Oral lactoferrin for the prevention of sepsis and necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev, 2, 2015, CD007137.
55. 55 Furukawa, M., Narahara, H., Yasuda, K., Johnston, J.M., Presence of platelet-activating factor-acetylhydrolase in milk. J Lipid Res 34 (1993), 1603–1609.
56. 56 Moya, F.R., Eguchi, H., Zhao, B., et al. Platelet-activating factor acetylhydrolase in term and preterm human milk: a preliminary report. J Pediatr Gastroenterol Nutr 19 (1994), 236–239.
57. 57 Hawkes, J.S., Bryan, D.L., James, M.J., Gibson, R.A., Cytokines (IL-1β, IL-6, TNF-α, TGF-β1, and TGF-β2) and prostaglandin E2 in human milk during the first three months postpartum. Pediatr Res 46 (1999), 194–199.
58. 58 Namachivayam, K., Blanco, C.L., Frost, B.L., et al. Preterm human milk contains a large pool of latent TGF-β, which can be activated by exogenous neuraminidase. Am J Physiol Gastrointest Liver Physiol 304 (2013), G1055–G1065.
59. 59 Chheda, S., Palkowetz, K.H., Garofalo, R., Rassin, D.K., Goldman, A.S., Decreased interleukin-10 production by neonatal monocytes and T cells: relationship to decreased production and expression of tumor necrosis factor-α and its receptors. Pediatr Res 40 (1996), 475–483.
60. 60 Chang, M., Suen, Y., Lee, S.M., et al. Transforming growth factor-beta 1, macrophage inflammatory protein-1 alpha, and interleukin-8 gene expression is lower in stimulated human neonatal compared with adult mononuclear cells. Blood 84 (1994), 118–124.
61. 61 Denning, T.L., Wang, Y.C., Patel, S.R., Williams, I.R., Pulendran, B., Lamina propria macrophages and dendritic cells differentially induce regulatory and interleukin 17-producing T cell responses. Nat Immunol 8 (2007), 1086–1094.
62. 62 Denning, T.L., Norris, B.A., Medina-Contreras, O., et al. Functional specializations of intestinal dendritic cell and macrophage subsets that control Th17 and regulatory T cell responses are dependent on the T cell/APC ratio, source of mouse strain, and regional localization. J Immunol 187 (2011), 733–747.
63. 63 Kuhn, R., Lohler, J., Rennick, D., Rajewsky, K., Muller, W., Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75 (1993), 263–274.
64. 64 Emami, C.N., Chokshi, N., Wang, J., et al. Role of interleukin-10 in the pathogenesis of necrotizing enterocolitis. Am J Surg 203 (2012), 428–435.
65. 65 Glocker, E.O., Kotlarz, D., Boztug, K., et al. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N Engl J Med 361 (2009), 2033–2045.
66. 66 Dvorak, B., Halpern, M.D., Holubec, H., et al. Maternal milk reduces severity of necrotizing enterocolitis and increases intestinal IL-10 in a neonatal rat model. Pediatr Res 53 (2003), 426–433.
67. 67 Fituch, C.C., Palkowetz, K.H., Goldman, A.S., Schanler, R.J., Concentrations of IL-10 in preterm human milk and in milk from mothers of infants with necrotizing enterocolitis. Acta Paediatr 93 (2004), 1496–1500.
68. 68 Mirpuri, J., Sotnikov, I., Myers, L., et al. Lactobacillus rhamnosus (LGG) regulates IL-10 signaling in the developing murine colon through upregulation of the IL-10R2 receptor subunit. PLoS One, 7, 2012, e51955.
69. 69 Maheshwari, A., Kelly, D.R., Nicola, T., et al. TGF-β2 suppresses macrophage cytokine production and mucosal inflammatory responses in the developing intestine. Gastroenterology 140 (2011), 242–253.
70. 70 Penttila, I.A., Milk-derived transforming growth factor-β and the infant immune response. J Pediatr 156 (2010), S21–S25.
71. 71 Yuen, D.E., Stratford, A.F., Vitamin A activation of transforming growth factor-β1 enhances porcine ileum wound healing in vitro. Pediatr Res 55 (2004), 935–939.
72. 72 Ogawa, J., Sasahara, A., Yoshida, T., et al. Role of transforming growth factor-β in breast milk for initiation of IgA production in newborn infants. Early Hum Dev 77 (2004), 67–75.
73. 73 Frost, B.L., Jilling, T., Lapin, B., Maheshwari, A., Caplan, M.S., Maternal breast milk transforming growth factor-beta and feeding intolerance in preterm infants. Pediatr Res 76 (2014), 386–393.
74. 74 Claud, E.C., Savidge, T., Walker, W.A., Modulation of human intestinal epithelial cell IL-8 secretion by human milk factors. Pediatr Res 53 (2003), 419–425.
75. 75 Hellstrom, A., Engstrom, E., Hard, A.L., et al. Postnatal serum insulin-like growth factor I deficiency is associated with retinopathy of prematurity and other complications of premature birth. Pediatrics 112 (2003), 1016–1020.
76. 76 Baregamian, N., Rychahou, P.G., Hawkins, H.K., Evers, B.M., Chung, D.H., Phosphatidylinositol 3-kinase pathway regulates hypoxia-inducible factor-1 to protect from intestinal injury during necrotizing enterocolitis. Surgery 142 (2007), 295–302.
77. 77 Ozen, S., Akisu, M., Baka, M., et al. Insulin-like growth factor attenuates apoptosis and mucosal damage in hypoxia/reoxygenation-induced intestinal injury. Biol Neonate 87 (2005), 91–96.
78. 78 Baregamian, N., Song, J., Chung, D.H., Effects of oxidative stress on intestinal type I insulin-like growth factor receptor expression. Eur J Pediatr Surg 22 (2012), 97–104.
79. 79 Coursodon, C.F., Dvorak, B., Epidermal growth factor and necrotizing enterocolitis. Curr Opin Pediatr 24 (2012), 160–164.
80. 80 Dvorak, B., Milk epidermal growth factor and gut protection. J Pediatr 156 (2010), S31–S35.
81. 81 Su, Y., Yang, J., Besner, G.E., HB-EGF promotes intestinal restitution by affecting integrin-extracellular matrix interactions and intercellular adhesions. Growth Factors 31 (2013), 39–55.
82. 82 Maynard, A.A., Dvorak, K., Khailova, L., et al. Epidermal growth factor reduces autophagy in intestinal epithelium and in the rat model of necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol 299 (2010), G614–G622.
83. 83 Clark, J.A., Doelle, S.M., Halpern, M.D., et al. Intestinal barrier failure during experimental necrotizing enterocolitis: protective effect of EGF treatment. Am J Physiol Gastrointest Liver Physiol 291 (2006), G938–G949.
84. 84 Good, M., Sodhi, C.P., Egan, C.E., et al. Breast milk protects against the development of necrotizing enterocolitis through inhibition of Toll-like receptor 4 in the intestinal epithelium via activation of the epidermal growth factor receptor. Mucosal Immunol 8 (2015), 1166–1179.
85. 85 Wei, J., Besner, G.E., M1 to M2 macrophage polarization in heparin-binding epidermal growth factor-like growth factor therapy for necrotizing enterocolitis. J Surg Res 197 (2015), 126–138.
86. 86 Dvorak, B., Fituch, C.C., Williams, C.S., Hurst, N.M., Schanler, R.J., Increased epidermal growth factor levels in human milk of mothers with extremely premature infants. Pediatr Res 54 (2003), 15–19.
87. 87 Warner, B.B., Ryan, A.L., Seeger, K., Leonard, A.C., Erwin, C.R., Warner, B.W., Ontogeny of salivary epidermal growth factor and necrotizing enterocolitis. J Pediatr 150 (2007), 358–363.
88. 88 Gupta, A., Lakhoo, K., Pritchard, N., Herbert, M., Epidermal growth factor in neonatal saliva. Eur J Pediatr Surg 18 (2008), 245–248.
89. 89 Wahab Mohamed, W.A., Aseeri, A.M., Cord blood epidermal growth factor as a possible predictor of necrotizing enterocolitis in very low birth weight infants. J Neonatal Perinatal Med 6 (2013), 257–262.
90. 90 Shin, C.E., Falcone, R.A. Jr, Stuart, L., Erwin, C.R., Warner, B.W., Diminished epidermal growth factor levels in infants with necrotizing enterocolitis. J Pediatr Surg 35 (2000), 173–176 [discussion 7].
91. 91 Dvorak, B., Halpern, M.D., Holubec, H., et al. Epidermal growth factor reduces the development of necrotizing enterocolitis in a neonatal rat model. Am J Physiol Gastrointest Liver Physiol 282 (2002), G156–G164.
92. 92 Dvorak, B., Khailova, L., Clark, J.A., et al. Comparison of epidermal growth factor and heparin-binding epidermal growth factor-like growth factor for prevention of experimental necrotizing enterocolitis. J Pediatr Gastroenterol Nutr 47 (2008), 11–18.
93. 93 Wei, J., Zhou, Y., Besner, G.E., Heparin-binding EGF-like growth factor and enteric neural stem cell transplantation in the prevention of experimental necrotizing enterocolitis in mice. Pediatr Res 78 (2015), 29–37.
94. 94 Yang, J., Watkins, D., Chen, C.L., Bhushan, B., Zhou, Y., Besner, G.E., Heparin-binding epidermal growth factor-like growth factor and mesenchymal stem cells act synergistically to prevent experimental necrotizing enterocolitis. J Am Coll Surg 215 (2012), 534–545.
95. 95 Chen, C.L., Yu, X., James, I.O., et al. Heparin-binding EGF-like growth factor protects intestinal stem cells from injury in a rat model of necrotizing enterocolitis. Lab Invest 92 (2012), 331–344.
96. 96 Yu, X., Radulescu, A., Zorko, N., Besner, G.E., Heparin-binding EGF-like growth factor increases intestinal microvascular blood flow in necrotizing enterocolitis. Gastroenterology 137 (2009), 221–230.
97. 97 Khailova, L., Dvorak, K., Arganbright, K.M., Williams, C.S., Halpern, M.D., Dvorak, B., Changes in hepatic cell junctions structure during experimental necrotizing enterocolitis: effect of EGF treatment. Pediatr Res 66 (2009), 140–144.
98. 98 Radulescu, A., Zorko, N.A., Yu, X., Besner, G.E., Preclinical neonatal rat studies of heparin-binding EGF-like growth factor in protection of the intestines from necrotizing enterocolitis. Pediatr Res 65 (2009), 437–442.
99. 99 Feng, J., El-Assal, O.N., Besner, G.E., Heparin-binding EGF-like growth factor (HB-EGF) and necrotizing enterocolitis. Semin Pediatr Surg 14 (2005), 167–174.
100. 100 Feng, J., El-Assal, O.N., Besner, G.E., Heparin-binding epidermal growth factor-like growth factor reduces intestinal apoptosis in neonatal rats with necrotizing enterocolitis. J Pediatr Surg 41 (2006), 742–747 [discussion-7].
101. 101 Feng, J., El-Assal, O.N., Besner, G.E., Heparin-binding epidermal growth factor-like growth factor decreases the incidence of necrotizing enterocolitis in neonatal rats. J Pediatr Surg 41 (2006), 144–149 [discussion-9].
102. 102 Halpern, M.D., Holubec, H., Clark, J.A., et al. Epidermal growth factor reduces hepatic sequelae in experimental necrotizing enterocolitis. Biol Neonate 89 (2006), 227–235.
103. 103 Halpern, M.D., Dominguez, J.A., Dvorakova, K., et al. Ileal cytokine dysregulation in experimental necrotizing enterocolitis is reduced by epidermal growth factor. J Pediatr Gastroenterol Nutr 36 (2003), 126–133.
104. 104 Sullivan, P.B., Lewindon, P.J., Cheng, C., et al. Intestinal mucosa remodeling by recombinant human epidermal growth factor (1–48) in neonates with severe necrotizing enterocolitis. J Pediatr Surg 42 (2007), 462–469.
105. 105 Boyle, J.T., Acid secretion from birth to adulthood. J Pediatr Gastroenterol Nutr 37:suppl 1 (2003), S12–S16.
106. 106 Grahnquist, L., Ruuska, T., Finkel, Y., Early development of human gastric H,K-adenosine triphosphatase. J Pediatr Gastroenterol Nutr 30 (2000), 533–537.
107. 107 Kelly, E.J., Newell, S.J., Brownlee, K.G., Primrose, J.N., Dear, P.R., Gastric acid secretion in preterm infants. Early Hum Dev 35 (1993), 215–220.
108. 108 More, K., Athalye-Jape, G., Rao, S., Patole, S., Association of inhibitors of gastric acid secretion and higher incidence of necrotizing enterocolitis in preterm very low-birth-weight infants. Am J Perinatol 30 (2013), 849–856.
109. 109 Terrin, G., Passariello, A., De Curtis, M., et al. Ranitidine is associated with infections, necrotizing enterocolitis, and fatal outcome in newborns. Pediatrics 129 (2012), e40–e45.
110. 110 Bianconi, S., Gudavalli, M., Sutija, V.G., Lopez, A.L., Barillas-Arias, L., Ron, N., Ranitidine and late-onset sepsis in the neonatal intensive care unit. J Perinat Med 35 (2007), 147–150.
111. 111 Graham, P.L. 3rd, Begg, M.D., Larson, E., Della-Latta, P., Allen, A., Saiman, L., Risk factors for late onset gram-negative sepsis in low birth weight infants hospitalized in the neonatal intensive care unit. Pediatr Infect Dis J 25 (2006), 113–117.
112. 112 Laboisse, C., Jarry, A., Branka, J.E., Merlin, D., Bou-Hanna, C., Vallette, G., Regulation of mucin exocytosis from intestinal goblet cells. Biochem Soc Trans 23 (1995), 810–813.
113. 113 Lievin-Le Moal, V., Servin, A.L., The front line of enteric host defense against unwelcome intrusion of harmful microorganisms: mucins, antimicrobial peptides, and microbiota. Clin Microbiol Rev 19 (2006), 315–337.
114. 114 Johansson, M.E., Sjovall, H., Hansson, G.C., The gastrointestinal mucus system in health and disease. Nat Rev Gastroenterol Hepatol 10 (2013), 352–361.
115. 115 Johansson, M.E., Ambort, D., Pelaseyed, T., et al. Composition and functional role of the mucus layers in the intestine. Cell Mol Life Sci 68 (2011), 3635–3641.
116. 116 Johansson, M.E., Larsson, J.M., Hansson, G.C., The two mucus layers of colon are organized by the MUC2 mucin, whereas the outer layer is a legislator of host-microbial interactions. Proc Natl Acad Sci U S A 108:suppl 1 (2011), 4659–4665.
117. 117 McElroy, S.J., Weitkamp, J.H., Innate Immunity in the Small Intestine of the Preterm Infant. Neoreviews 12 (2011), e517–e526.
118. 118 Pelaseyed, T., Bergstrom, J.H., Gustafsson, J.K., et al. The mucus and mucins of the goblet cells and enterocytes provide the first defense line of the gastrointestinal tract and interact with the immune system. Immunol Rev 260 (2014), 8–20.
119. 119 Corfield, A.P., Carroll, D., Myerscough, N., Probert, C.S., Mucins in the gastrointestinal tract in health and disease. Front Biosci 6 (2001), D1321–D1357.
120. 120 Louis, N.A., Hamilton, K.E., Canny, G., Shekels, L.L., Ho, S.B., Colgan, S.P., Selective induction of mucin-3 by hypoxia in intestinal epithelia. J Cell Biochem 99 (2006), 1616–1627.
121. 121 McElroy, S.J., Prince, L.S., Weitkamp, J.H., Reese, J., Slaughter, J.C., Polk, D.B., Tumor necrosis factor receptor 1-dependent depletion of mucus in immature small intestine: a potential role in neonatal necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol 301 (2011), G656–G666.
122. 122 Schaart, M.W., de Bruijn, A.C., Bouwman, D.M., et al. Epithelial functions of the residual bowel after surgery for necrotising enterocolitis in human infants. J Pediatr Gastroenterol Nutr 49 (2009), 31–41.
123. 123 McElroy, S.J., Prince, L.S., Weitkamp, J.H., Reese, J., Slaughter, J.C., Polk, D.B., Tumor necrosis factor receptor 1-dependent depletion of mucus in immature small intestine: a potential role in neonatal necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol 301 (2011), G656–G666.
124. 124 Martin, N.A., Mount Patrick, S.K., Estrada, T.E., et al. Active transport of bile acids decreases mucin 2 in neonatal ileum: implications for development of necrotizing enterocolitis. PLoS One, 6, 2011, e27191.
125. 125 Zhang, B.H., Yu, H.G., Sheng, Z.X., Luo, H.S., Yu, J.P., The therapeutic effect of recombinant human trefoil factor 3 on hypoxia-induced necrotizing enterocolitis in immature rat. Regul Pept 116 (2003), 53–60.
126. 126 Fanca-Berthon, P., Michel, C., Pagniez, A., et al. Intrauterine growth restriction alters postnatal colonic barrier maturation in rats. Pediatr Res 66 (2009), 47–52.
127. 127 Ree, I.M., Smits-Wintjens, V.E., Rijntjes-Jacobs, E.G., et al. Necrotizing enterocolitis in small-for-gestational-age neonates: a matched case-control study. Neonatology 105 (2014), 74–78.
128. 128 Che, L., Thymann, T., Bering, S.B., et al. IUGR does not predispose to necrotizing enterocolitis or compromise postnatal intestinal adaptation in preterm pigs. Pediatr Res 67 (2010), 54–59.
129. 129 Kliegman, R.M., Hack, M., Jones, P., Fanaroff, A.A., Epidemiologic study of necrotizing enterocolitis among low-birth-weight infants. Absence of identifiable risk factors. J Pediatr 100 (1982), 440–444.
130. 130 Dong, L., Zhong, X., Ahmad, H., et al. Intrauterine growth restriction impairs small intestinal mucosal immunity in neonatal piglets. J Histochem Cytochem 62 (2014), 510–518.
131. 131 Fung, C.M., White, J.R., Brown, A.S., et al. Intrauterine growth restriction alters mouse intestinal architecture during development. PLoS One, 11, 2016, e0146542.
132. 132 Halpern, M.D., Denning, P.W., The role of intestinal epithelial barrier function in the development of NEC. Tissue Barriers, 3, 2015, e1000707.
133. 133 Anderson, J.M., Van Itallie, C.M., Tight junctions. Curr Biol 18 (2008), R941–R943.
134. 134 Balda, M.S., Fallon, M.B., Van Itallie, C.M., Anderson, J.M., Structure, regulation, and pathophysiology of tight junctions in the gastrointestinal tract. Yale J Biol Med 65 (1992), 725–735 [discussion 37–40].
135. 135 Lebenthal, A., Lebenthal, E., The ontogeny of the small intestinal epithelium. JPEN J Parenter Enteral Nutr 23 (1999), S3–S6.
136. 136 Goldman, A.S., Modulation of the gastrointestinal tract of infants by human milk. Interfaces and interactions. An evolutionary perspective. J Nutr 130 (2000), 426S–431SS.
137. 137 Colome, G., Sierra, C., Blasco, J., Garcia, M.V., Valverde, E., Sanchez, E., Intestinal permeability in different feedings in infancy. Acta Paediatr 96 (2007), 69–72.
138. 138 Weaver, L.T., Laker, M.F., Nelson, R., Lucas, A., Milk feeding and changes in intestinal permeability and morphology in the newborn. J Pediatr Gastroenterol Nutr 6 (1987), 351–358.
139. 139 Henning, S.J., Development of the gastrointestinal tract. Proc Nutr Soc 45 (1986), 39–44.
140. 140 Patel, R.M., Myers, L.S., Kurundkar, A.R., Maheshwari, A., Nusrat, A., Lin, P.W., Probiotic bacteria induce maturation of intestinal claudin 3 expression and barrier function. Am J Pathol 180 (2012), 626–635.
141. 141 Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S., Medzhitov, R., Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118 (2004), 229–241.
142. 142 Weaver, L.T., Laker, M.F., Nelson, R., Intestinal permeability in the newborn. Arch Dis Child 59 (1984), 236–241.
143. 143 van Elburg, R.M., Fetter, W.P., Bunkers, C.M., Heymans, H.S., Intestinal permeability in relation to birth weight and gestational and postnatal age. Arch Dis Child Fetal Neonatal Ed 88 (2003), F52–F55.
144. 144 Henry, M.C., Moss, R.L., Neonatal necrotizing enterocolitis. Semin Pediatr Surg 17 (2008), 98–109.
145. 145 Grave, G.D., Nelson, S.A., Walker, W.A., et al. New therapies and preventive approaches for necrotizing enterocolitis: report of a research planning workshop. Pediatr Res 62 (2007), 510–514.
146. 146 Lin, P.W., Nasr, T.R., Stoll, B.J., Necrotizing enterocolitis: recent scientific advances in pathophysiology and prevention. Semin Perinatol 32 (2008), 70–82.
147. 147 Bjarnason, I., Intestinal permeability. Gut 35 (1994), S18–S22.
148. 148 Bergmann, K.R., Liu, S.X., Tian, R., et al. Bifidobacteria stabilize claudins at tight junctions and prevent intestinal barrier dysfunction in mouse necrotizing enterocolitis. Am J Pathol 182 (2013), 1595–1606.
149. + T lymphocytes are present in the premature intestine but selectively reduced in surgical necrotizing enterocolitis. PLoS One, 9, 2014, e99042.
150. 150 Rentea, R.M., Liedel, J.L., Welak, S.R., et al. Intestinal alkaline phosphatase administration in newborns is protective of gut barrier function in a neonatal necrotizing enterocolitis rat model. J Pediatr Surg 47 (2012), 1135–1142.
151. 151 Hogberg, N., Stenback, A., Carlsson, P.O., Wanders, A., Lilja, H.E., Genes regulating tight junctions and cell adhesion are altered in early experimental necrotizing enterocolitis. J Pediatr Surg 48 (2013), 2308–2312.
152. 152 Shiou, S.R., Yu, Y., Chen, S., et al. Erythropoietin protects intestinal epithelial barrier function and lowers the incidence of experimental neonatal necrotizing enterocolitis. J Biol Chem 286 (2011), 12123–12132.
153. 153 Prasad, S., Mingrino, R., Kaukinen, K., et al. Inflammatory processes have differential effects on claudins 2, 3 and 4 in colonic epithelial cells. Lab Invest 85 (2005), 1139–1162.
154. 154 Bruewer, M., Luegering, A., Kucharzik, T., et al. Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms. J Immunol 171 (2003), 6164–6172.
155. 155 Lapointe, T.K., Buret, A.G., Interleukin-18 facilitates neutrophil transmigration via myosin light chain kinase-dependent disruption of occludin, without altering epithelial permeability. Am J Physiol Gastrointest Liver Physiol 302 (2011), G343–G351.
156. 156 Marchiando, A.M., Shen, L., Graham, W.V., et al. The epithelial barrier is maintained by in vivo tight junction expansion during pathologic intestinal epithelial shedding. Gastroenterology, 140, 2011 1208–1218.e1–e2.
157. 157 Fries, W., Muja, C., Crisafulli, C., Cuzzocrea, S., Mazzon, E., Dynamics of enterocyte tight junctions: effect of experimental colitis and two different anti-TNF strategies. Am J Physiol Gastrointest Liver Physiol 294 (2008), G938–G947.
158. 158 Halpern, M.D., Clark, J.A., Saunders, T.A., et al. Reduction of experimental necrotizing enterocolitis with anti-TNF-α. Am J Physiol Gastrointest Liver Physiol 290 (2006), G757–G764.
159. 159 Thuijls, G., Derikx, J.P., van Wijck, K., et al. Non-invasive markers for early diagnosis and determination of the severity of necrotizing enterocolitis. Ann Surg 251 (2010), 1174–1180.
160. 160 Nanthakumar, N., Meng, D., Goldstein, A.M., et al. The mechanism of excessive intestinal inflammation in necrotizing enterocolitis: an immature innate immune response. PLoS One, 6, 2011, e17776.
161. 161 Sampath, V., Le, M., Lane, L., et al. The NFKB1 (g.-24519delATTG) variant is associated with necrotizing enterocolitis (NEC) in premature infants. J Surg Res 169 (2011), e51–e57.
162. 162 Chan, K.Y., Leung, K.T., Tam, Y.H., et al. Genome-wide expression profiles of necrotizing enterocolitis versus spontaneous intestinal perforation in human intestinal tissues: dysregulation of functional pathways. Ann Surg 260 (2014), 1128–1137.
163. 163 Ganguli, K., Meng, D., Rautava, S., Lu, L., Walker, W.A., Nanthakumar, N., Probiotics prevent necrotizing enterocolitis by modulating enterocyte genes that regulate innate immune-mediated inflammation. Am J Physiol Gastrointest Liver Physiol 304 (2013), G132–G141.
164. 164 Hartel, C., Hartz, A., Pagel, J., et al. NOD2 loss-of-function mutations and risks of necrotizing enterocolitis or focal intestinal perforation in very low-birth-weight infants. Inflamm Bowel Dis 22 (2016), 249–256.
165. 165 Zhou, W., Li, W., Zheng, X.H., Rong, X., Huang, L.G., Glutamine downregulates TLR-2 and TLR-4 expression and protects intestinal tract in preterm neonatal rats with necrotizing enterocolitis. J Pediatr Surg 49 (2014), 1057–1063.
166. 166 Khailova, L., Mount Patrick, S.K., Arganbright, K.M., Halpern, M.D., Kinouchi, T., Dvorak, B., Bifidobacterium bifidum reduces apoptosis in the intestinal epithelium in necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol 299 (2010), G1118–G1127.
167. 167 Le Mandat Schultz, A., Bonnard, A., Barreau, F., et al. Expression of TLR-2, TLR-4, NOD2 and pNF-κB in a neonatal rat model of necrotizing enterocolitis. PLoS One, 2, 2007, e1102.
168. 168 Sodhi, C.P., Neal, M.D., Siggers, R., et al. Intestinal epithelial toll-like receptor 4 regulates goblet cell development and is required for necrotizing enterocolitis in mice. Gastroenterology 143 (2012), 708–718 e5.
169. 169 Siggers, J., Sangild, P.T., Jensen, T.K., et al. Transition from parenteral to enteral nutrition induces immediate diet-dependent gut histological and immunological responses in preterm neonates. Am J Physiol Gastrointest Liver Physiol 301 (2011), G435–G445.
170. 170 Lu, J., Caplan, M.S., Li, D., Jilling, T., Polyunsaturated fatty acids block platelet-activating factor-induced phosphatidylinositol 3 kinase/Akt-mediated apoptosis in intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 294 (2008), G1181–G1190.
171. 171 Ostergaard, M.V., Cilieborg, M.S., Skovgaard, K., Schmidt, M., Sangild, P.T., Bering, S.B., Preterm birth reduces nutrient absorption with limited effect on immune gene expression and gut colonization in pigs. J Pediatr Gastroenterol Nutr 61 (2015), 481–490.
172. 172 Neal, M.D., Richardson, W.M., Sodhi, C.P., Russo, A., Hackam, D.J., Intestinal stem cells and their roles during mucosal injury and repair. J Surg Res 167 (2011), 1–8.
173. 173 Good, M., Siggers, R.H., Sodhi, C.P., et al. Amniotic fluid inhibits Toll-like receptor 4 signaling in the fetal and neonatal intestinal epithelium. Proc Natl Acad Sci U S A 109 (2012), 11330–11335.
174. 174 Jilling, T., Simon, D., Lu, J., et al. The roles of bacteria and TLR4 in rat and murine models of necrotizing enterocolitis. J Immunol 177 (2006), 3273–3282.
175. 175 Richardson, W.M., Sodhi, C.P., Russo, A., et al. Nucleotide-binding oligomerization domain-2 inhibits toll-like receptor-4 signaling in the intestinal epithelium. Gastroenterology 139 (2010), 904–917 e1–e6.
176. 176 Abreu, M.T., Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function. Nat Rev Immunol 10 (2010), 131–144.
177. 177 Hackam, D.J., Good, M., Sodhi, C.P., Mechanisms of gut barrier failure in the pathogenesis of necrotizing enterocolitis: Toll-like receptors throw the switch. Semin Pediatr Surg 22 (2013), 76–82.
178. 178 Hackam, D.J., Afrazi, A., Good, M., Sodhi, C.P., Innate immune signaling in the pathogenesis of necrotizing enterocolitis. Clin Dev Immunol, 2013, 2013, 475415.
179. 179 Hunter, C.J., De Plaen, I.G., Inflammatory signaling in NEC: role of NF-κB, cytokines and other inflammatory mediators. Pathophysiology 21 (2014), 55–65.
180. 180 Frost, B.L., Jilling, T., Caplan, M.S., The importance of pro-inflammatory signaling in neonatal necrotizing enterocolitis. Semin Perinatol 32 (2008), 100–106.
181. 181 Soliman, A., Michelsen, K.S., Karahashi, H., et al. Platelet-activating factor induces TLR4 expression in intestinal epithelial cells: implication for the pathogenesis of necrotizing enterocolitis. PLoS One, 5, 2010, e15044.
182. 182 Gordon, P., Christensen, R., Weitkamp, J.H., Maheshwari, A., Mapping the new world of necrotizing enterocolitis (NEC): review and opinion. EJ Neonatol Res 2 (2012), 145–172.
183. 183 Good, M., Sodhi, C.P., Ozolek, J.A., et al. Lactobacillus rhamnosus HN001 decreases the severity of necrotizing enterocolitis in neonatal mice and preterm piglets: evidence in mice for a role of TLR9. Am J Physiol Gastrointest Liver Physiol 306 (2014), G1021–G1032.
184. 184 Arciero, J., Bard Ermentrout, G., Siggers, R., et al. Modeling the interactions of bacteria and Toll-like receptor-mediated inflammation in necrotizing enterocolitis. J Theor Biol 321 (2013), 83–99.
185. 185 Liu, Y., Zhu, L., Fatheree, N.Y., et al. Changes in intestinal Toll-like receptors and cytokines precede histological injury in a rat model of necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol 297 (2009), G442–G450.
186. 186 Gribar, S.C., Sodhi, C.P., Richardson, W.M., et al. Reciprocal expression and signaling of TLR4 and TLR9 in the pathogenesis and treatment of necrotizing enterocolitis. J Immunol 182 (2009), 636–646.
187. 187 Selsted, M.E., Ouellette, A.J., Mammalian defensins in the antimicrobial immune response. Nat Immunol 6 (2005), 551–557.
188. 188 Perez-Lopez, A., Behnsen, J., Nuccio, S.P., Raffatellu, M., Mucosal immunity to pathogenic intestinal bacteria. Nat Rev Immunol 16 (2016), 135–148.
189. 189 Otte, J.M., Kiehne, K., Herzig, K.H., Antimicrobial peptides in innate immunity of the human intestine. J Gastroenterol 38 (2003), 717–726.
190. 190 Fabisiak, A., Murawska, N., Fichna, J., LL-37: cathelicidin-related antimicrobial peptide with pleiotropic activity. Pharmacol Rep, 2016.
191. 191 Salzman, N.H., Underwood, M.A., Bevins, C.L., Paneth cells, defensins, and the commensal microbiota: a hypothesis on intimate interplay at the intestinal mucosa. Semin Immunol 19 (2007), 70–83.
192. 192 Ganz, T., Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol 3 (2003), 710–720.
193. 193 Lin, P.W., Neish, A.S., Innate immunity and epithelial biology: special considerations in the neonatal gut. Neu, J., (eds.) Gastroenterology and Nutrition: Neonatal Questions and Controversies, 2008, Saunders, Philadelphia, 51–72.
194. 194 Lin, P.W., Simon, P.O. Jr, Gewirtz, A.T., et al. Paneth cell cryptdins act in vitro as apical paracrine regulators of the innate inflammatory response. J Biol Chem 279 (2004), 19902–19907.
195. 195 Sheng, Q., Lv, Z., Cai, W., et al. Human β-defensin-3 promotes intestinal epithelial cell migration and reduces the development of necrotizing enterocolitis in a neonatal rat model. Pediatr Res 76 (2014), 269–279.
196. 196 Campeotto, F., Baldassarre, M., Laforgia, N., et al. Fecal expression of human β-defensin-2 following birth. Neonatology 98 (2010), 365–369.
197. 197 Jenke, A.C., Postberg, J., Mariel, B., et al. S100A12 and hBD2 correlate with the composition of the fecal microflora in ELBW infants and expansion of E. coli is associated with NEC. Biomed Res Int, 2013, 2013, 150372.
198. 198 Jenke, A.C., Zilbauer, M., Postberg, J., Wirth, S., Human β-defensin 2 expression in ELBW infants with severe necrotizing enterocolitis. Pediatr Res 72 (2012), 513–520.
199. 199 Mallow, E.B., Harris, A., Salzman, N., et al. Human enteric defensins. Gene structure and developmental expression. J Biol Chem 271 (1996), 4038–4045.
200. 200 Rumbo, M., Schiffrin, E.J., Ontogeny of intestinal epithelium immune functions: developmental and environmental regulation. Cell Mol Life Sci 62 (2005), 1288–1296.
201. 201 Heida, F.H., Beyduz, G., Bulthuis, M.L., et al. Paneth cells in the developing gut: when do they arise and when are they immune competent?. Pediatr Res, 2016.
202. 202 Salzman, N.H., Polin, R.A., Harris, M.C., et al. Enteric defensin expression in necrotizing enterocolitis. Pediatr Res 44 (1998), 20–26.
203. 203 McElroy, S.J., Castle, S.L., Bernard, J.K., et al. The ErbB4 ligand neuregulin-4 protects against experimental necrotizing enterocolitis. Am J Pathol 184 (2014), 2768–2778.
204. 204 Underwood, M.A., Kananurak, A., Coursodon, C.F., et al. Bifidobacterium bifidum in a rat model of necrotizing enterocolitis: antimicrobial peptide and protein responses. Pediatr Res 71 (2012), 546–551.
205. 205 McElroy, S.J., Underwood, M.A., Sherman, M.P., Paneth cells and necrotizing enterocolitis: a novel hypothesis for disease pathogenesis. Neonatology 103 (2013), 10–20.
206. 206 Coutinho, H.B., da Mota, H.C., Coutinho, V.B., et al. Absence of lysozyme (muramidase) in the intestinal Paneth cells of newborn infants with necrotising enterocolitis. J Clin Pathol 51 (1998), 512–514.
207. 207 Puiman, P.J., Burger-Van Paassen, N., Schaart, M.W., et al. Paneth cell hyperplasia and metaplasia in necrotizing enterocolitis. Pediatr Res 69 (2011), 217–223.
208. 208 Sperandio, B., Fischer, N., Sansonetti, P.J., Mucosal physical and chemical innate barriers: Lessons from microbial evasion strategies. Semin Immunol 27 (2015), 111–118.
209. 209 Kinnebrew, M.A., Pamer, E.G., Innate immune signaling in defense against intestinal microbes. Immunol Rev 245 (2012), 113–131.
210. 210 Cheroutre, H., Starting at the beginning: new perspectives on the biology of mucosal T cells. Annu Rev Immunol 22 (2004), 217–246.
211. 211 Cheroutre, H., Lambolez, F., The thymus chapter in the life of gut-specific intra epithelial lymphocytes. Curr Opin Immunol 20 (2008), 185–191.
212. 212 Cheroutre, H., IELs: enforcing law and order in the court of the intestinal epithelium. Immunol Rev 206 (2005), 114–131.
213. 213 Hayday, A., Tigelaar, R., Immunoregulation in the tissues by γδ T cells. Nat Rev Immunol 3 (2003), 233–242.
214. + T helper cells. Cell 126 (2006), 1121–1133.
215. 215 Maxwell, J.R., Zhang, Y., Brown, W.A., et al. Differential roles for Interleukin-23 and interleukin-17 in intestinal immunoregulation. Immunity 43 (2015), 739–750.
216. 216 Lee, J.S., Tato, C.M., Joyce-Shaikh, B., et al. Interleukin-23-independent IL-17 production regulates intestinal epithelial permeability. Immunity 43 (2015), 727–738.
217. 217 Symons, A., Budelsky, A.L., Towne, J.E., Are Th17 cells in the gut pathogenic or protective?. Mucosal Immunol 5 (2012), 4–6.
218. 218 Ramirez, K., Witherden, D.A., Havran, W.L., All hands on DE(T)C: epithelial-resident γδ T cells respond to tissue injury. Cell Immunol 296 (2015), 57–61.
219. 219 Vantourout, P., Hayday, A., Six-of-the-best: unique contributions of γδ T cells to immunology. Nat Rev Immunol 13 (2013), 88–100.
220. 220 Vivier, E., Tomasello, E., Baratin, M., Walzer, T., Ugolini, S., Functions of natural killer cells. Nat Immunol 9 (2008), 503–510.
221. 221 Hall, L.J., Murphy, C.T., Quinlan, A., et al. Natural killer cells protect mice from DSS-induced colitis by regulating neutrophil function via the NKG2A receptor. Mucosal Immunol 6 (2013), 1016–1026.
222. 222 Fort, M.M., Leach, M.W., Rennick, D.M., A role for NK cells as regulators of CD4+ T cells in a transfer model of colitis. J Immunol 161 (1998), 3256–3261.
223. 223 Bochennek, K., Fryns, E., Wittekindt, B., et al. Immune cell subsets at birth may help to predict risk of late-onset sepsis and necrotizing enterocolitis in preterm infants. Early Hum Dev 93 (2016), 9–16.
224. 224 Tait Wojno, E.D., Artis, D., Innate lymphoid cells: balancing immunity, inflammation, and tissue repair in the intestine. Cell Host Microbe 12 (2012), 445–457.
225. 225 Fournier, B.M., Parkos, C.A., The role of neutrophils during intestinal inflammation. Mucosal Immunol 5 (2012), 354–366.
226. 226 Tanner, S.M., Berryhill, T.F., Ellenburg, J.L., et al. Pathogenesis of necrotizing enterocolitis: modeling the innate immune response. Am J Pathol 185 (2015), 4–16.
227. 227 Christensen, R.D., Yoder, B.A., Baer, V.L., Snow, G.L., Butler, A., Early-onset neutropenia in small-for-gestational-age infants. Pediatrics 136 (2015), e1259–e1267.
228. 228 Emami, C.N., Mittal, R., Wang, L., Ford, H.R., Prasadarao, N.V., Role of neutrophils and macrophages in the pathogenesis of necrotizing enterocolitis caused by Cronobacter sakazakii. J Surg Res 172 (2012), 18–28.
229. 229 MohanKumar, K., Kaza, N., Jagadeeswaran, R., et al. Gut mucosal injury in neonates is marked by macrophage infiltration in contrast to pleomorphic infiltrates in adult: evidence from an animal model. Am J Physiol Gastrointest Liver Physiol 303 (2012), G93–G102.
230. 230 Zindl, C.L., Lai, J.F., Lee, Y.K., et al. IL-22-producing neutrophils contribute to antimicrobial defense and restitution of colonic epithelial integrity during colitis. Proc Natl Acad Sci U S A 110 (2013), 12768–12773.
231. 231 Parks, O.B., Pociask, D.A., Hodzic, Z., Kolls, J.K., Good, M., Interleukin-22 signaling in the regulation of intestinal health and disease. Front Cell Dev Biol, 3, 2015, 85.
232. 232 Dudakov, J.A., Hanash, A.M., van den Brink, M.R., Interleukin-22: immunobiology and pathology. Annu Rev Immunol 33 (2015), 747–785.
233. 233 Mizoguchi, A., Healing of intestinal inflammation by IL-22. Inflamm Bowel Dis 18 (2012), 1777–1784.
234. 234 Renz, H., Brandtzaeg, P., Hornef, M., The impact of perinatal immune development on mucosal homeostasis and chronic inflammation. Nat Rev Immunol 12 (2012), 9–23.
235. 235 Lotz, M., Gutle, D., Walther, S., Menard, S., Bogdan, C., Hornef, M.W., Postnatal acquisition of endotoxin tolerance in intestinal epithelial cells. J Exp Med 203 (2006), 973–984.
236. 236 Remon, J., Kampanatkosol, R., Kaul, R.R., Muraskas, J.K., Christensen, R.D., Maheshwari, A., Acute drop in blood monocyte count differentiates NEC from other causes of feeding intolerance. J Perinatol 34 (2014), 549–554.
237. 237 MohanKumar, K., Namachivayam, K., Chapalamadugu, K.C., et al. Smad7 interrupts TGF-β signaling in intestinal macrophages and promotes inflammatory activation of these cells during necrotizing enterocolitis. Pediatr Res, 2016.
238. 238 Bhatia, A.M., Stoll, B.J., Cismowski, M.J., Hamrick, S.E., Cytokine levels in the preterm infant with neonatal intestinal injury. Am J Perinatol 31 (2014), 489–496.
239. 239 Gross, M., Salame, T.M., Jung, S., Guardians of the gut—murine intestinal macrophages and dendritic cells. Front Immunol, 6, 2015, 254.
240. 240 Bogunovic, M., Mortha, A., Muller, P.A., Merad, M., Mononuclear phagocyte diversity in the intestine. Immunol Res 54 (2012), 37–49.
241. 241 Starcevic, V., Contrasting patterns in the relationship between hypochondriasis and narcissism. Br J Med Psychol 62:Pt 4 (1989), 311–323.
242. 242 Coombes, J.L., Powrie, F., Dendritic cells in intestinal immune regulation. Nat Rev Immunol 8 (2008), 435–446.
243. 243 Emami, C.N., Mittal, R., Wang, L., Ford, H.R., Prasadarao, N.V., Recruitment of dendritic cells is responsible for intestinal epithelial damage in the pathogenesis of necrotizing enterocolitis by Cronobacter sakazakii. J Immunol 186 (2011), 7067–7079.
244. 244 Egan, C.E., Sodhi, C.P., Good, M., et al. Toll-like receptor 4-mediated lymphocyte influx induces neonatal necrotizing enterocolitis. J Clin Invest, 2015.
245. 245 Weitkamp, J.H., Koyama, T., Rock, M.T., et al. Necrotising enterocolitis is characterised by disrupted immune regulation and diminished mucosal regulatory (FOXP3)/effector (CD4, CD8) T cell ratios. Gut 62 (2013), 73–82.